One microcap biotech is charging headfirst into treacherous IPO waters, jumping to Nasdaq with modest raise
It’s a tough market right now for biotech IPOs, but one small company is taking the public leap Friday with a modest initial offering. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
